Literature DB >> 33351812

The burden of serious non-AIDS-defining events among admitted cART-naive AIDS patients in China: An observational cohort study.

Yu Wang1, Hongyuan Liang1, Ling Zhang1, Zhe Zhang1, Liang Wu1, Liang Ni1, Guiju Gao1, Di Yang1, Hongxin Zhao1, Jiang Xiao1.   

Abstract

The objective of this study was to elucidate the burden, risk factors, and prognosis of serious non-AIDS-defining events among admitted cART-naive AIDS patients in China. The evaluation of the burden, risk factors and prognosis of serious NADEs was carried out among 1309 cART-naive AIDS patients (median age: 38.2 years, range: 18-78 years) admitted in Beijing Ditan Hospital between January 2009 and December 2018. Among 1309 patients, 143 patients (10.9%) had at least one serious NADEs, including 49 (3.8%) with cerebrovascular diseases, 37 (2.8%) with non-AIDS-defining cancers, 28 (2.1%) with chronic kidney diseases, 26 (2.0%) with cardiovascular diseases, and 18 (1.4%) with liver cirrhosis. Serious NADEs distributed in different age and CD4 levels, especially with age ≥50 years and CD4 ≤350 cells/ul. Other traditional risk factors, including cigarette smoking (OR = 1.9, 95%CI = 1.3-2.8, p = 0.002), hypertension (OR = 2.5, 95%CI = 1.7-3.7, p<0.001), chronic HCV infection (OR = 2.8, 95%CI = 1.4-5.6, p = 0.004), and hypercholesterolemia (OR = 4.1, 95% CI = 1.2-14.1, p = 0.026), were also associated with serious NADEs. Seventeen cases (1.3%) with serious NADEs died among hospitalized cART-naive AIDS patients, and severe pneumonia (HR = 5.5, 95%CI = 1.9-15.9, p<0.001) and AIDS-defining cancers (HR = 3.8, 95%CI = 1.1-13.2, p = 0.038) were identified as risk factors associated with an increased hazard of mortality among these patients with serious NADEs. Serious NADEs also occurred in cART-naive AIDS patients in China with low prevalence. Our results reminded physicians that early screening of serious NADEs, timely intervention of their risk factors, management of severe AIDS-defining events, multi-disciplinary cooperation, and early initiation of cART were essential to reduce the burden of serious NADEs.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33351812      PMCID: PMC7755215          DOI: 10.1371/journal.pone.0243773

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  41 in total

1.  Greater burden of chronic comorbidities and co-medications among people living with HIV versus people without HIV in Japan: A hospital claims database study.

Authors:  Daniel J Ruzicka; Kentaro Imai; Kenichi Takahashi; Toshio Naito
Journal:  J Infect Chemother       Date:  2018-11-03       Impact factor: 2.211

2.  Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites.

Authors:  W H Belloso; L C Orellana; B Grinsztejn; J S Madero; A La Rosa; V G Veloso; J Sanchez; R Ismerio Moreira; B Crabtree-Ramirez; O Garcia Messina; M B Lasala; J Peinado; M H Losso
Journal:  HIV Med       Date:  2010-03-21       Impact factor: 3.180

3.  HIV and Aging.

Authors:  Kris Ann Oursler; John David Sorkin
Journal:  Int J Infect Dis       Date:  2016-12       Impact factor: 3.623

4.  Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis.

Authors:  H Nina Kim; Robin Nance; Stephen Van Rompaey; Joseph C Delaney; Heidi M Crane; Edward R Cachay; Elvin Geng; Stephen L Boswell; Benigno Rodriguez; Joseph J Eron; Michael Saag; Richard D Moore; Mari M Kitahata
Journal:  J Acquir Immune Defic Syndr       Date:  2016-08-01       Impact factor: 3.731

5.  Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.

Authors:  C Castellares; P Barreiro; L Martín-Carbonero; P Labarga; M E Vispo; R Casado; L Galindo; P García-Gascó; J García-Samaniego; V Soriano
Journal:  J Viral Hepat       Date:  2008-03       Impact factor: 3.728

Review 6.  Immune activation and immune aging in HIV infection.

Authors:  Victor Appay; Anthony D Kelleher
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

7.  Malnutrition and lipid abnormalities in antiretroviral naïve HIV-infected adults in Addis Ababa: A cross-sectional study.

Authors:  Melaku Adal; Rawleigh Howe; Desta Kassa; Abraham Aseffa; Beyene Petros
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

8.  HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study.

Authors:  Curtis L Cooper; Chrissi Galanakis; Jessy Donelle; Jeff Kwong; Rob Boyd; Lisa Boucher; Claire E Kendall
Journal:  BMC Infect Dis       Date:  2019-08-23       Impact factor: 3.090

9.  Lipid Profile of Anti-Retroviral Treatment-Naïve HIV-Infected Patients in Jos, Nigeria.

Authors:  Ca Daniyam; Mo Iroezindu
Journal:  Ann Med Health Sci Res       Date:  2013-01

10.  Comorbidities and the use of comedications in people living with HIV on antiretroviral therapy in Japan: a cross-sectional study using a hospital claims database.

Authors:  Daniel J Ruzicka; Kentaro Imai; Kenichi Takahashi; Toshio Naito
Journal:  BMJ Open       Date:  2018-06-14       Impact factor: 2.692

View more
  1 in total

1.  Stroke among highly active antiretroviral therapy-naive people living with the human immunodeficiency virus in China: a retrospective study of the characteristics, risk factors, and prognosis.

Authors:  Ling Zhang; Yu Wang; Qiuhua Xu; Wei Zhang; Hongyuan Liang; Liang Wu; Liang Ni; Guiju Gao; Di Yang; Hongxin Zhao; Jiang Xiao
Journal:  BMC Infect Dis       Date:  2022-01-04       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.